This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Crispr Therapeutics Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Hui Yu - Innovator in CAR-T Cell Manufacturing
Introduction
Hui Yu is a prominent inventor based in Cambridge, MA (US), known for his contributions to the field of cellular therapies. He has been instrumental in advancing methods for manufacturing CAR-T cells, which are pivotal in cancer treatment.
Latest Patents
Hui Yu holds 3 patents that focus on innovative techniques in cell manufacturing. His latest patents include "Methods of Manufacturing CAR-T Cells" and "Manufacturing Process for Making T Cells Expressing Chimeric Antigen Receptors." These patents reflect his commitment to enhancing the efficacy of immunotherapies.
Career Highlights
Hui Yu is currently associated with Crispr Therapeutics AG, a leading company in gene editing and cellular therapies. His work at Crispr Therapeutics AG has positioned him at the forefront of biotechnological advancements, particularly in the development of CAR-T cell therapies.
Collaborations
Hui collaborates with talented individuals in his field, including Demetrios Kalaitzidis and Siyuan Tan. Their combined expertise fosters innovation and drives progress in cellular manufacturing techniques.
Conclusion
Hui Yu's contributions to CAR-T cell manufacturing and his innovative patents underscore his significant role in the biotechnology sector. His work continues to influence the future of cancer treatment and cellular therapies.